Norman Hardman

Directeur Général chez Oxalis Partners LLC

Profil

Norman Hardman currently works at Oxalis Partners LLC, as President & Chief Executive Officer from 2006 and Anosos Biotherapeutics LLC, as Chief Executive Officer.
Dr. Hardman also formerly worked at Amicus Therapeutics, Inc., as President & Chief Executive Officer from 2002 to 2004, Lifearc, as Chief Executive Officer from 2002 to 2003, ValiRx Plc, as Non-Executive Director, Chelsea Therapeutics International Ltd., as Independent Director from 2008 to 2012, Chelsea Therapeutics, Inc., as Director, AERES Biomedical Ltd., as Director, Enzon Pharmaceuticals, Inc., as Senior Vice President-Technology in 2003, gMed., Inc., as President & Chief Operating Officer, Onyx Pharmaceuticals, Inc., as Chief Operating Officer, Novartis AG, as Head-UK Research & Development Operations, and BASF Performance Products Ltd. (United Kingdom), as Head-Research & Development.
Dr. Hardman received his doctorate degree from The University of Manchester and undergraduate degree from the University of London.

Postes actifs de Norman Hardman

Sociétés	Poste	Début
Oxalis Partners LLC	Directeur Général	01/05/2006
Anosos Biotherapeutics LLC	Directeur Général	-

Anciens postes connus de Norman Hardman

Sociétés	Poste	Fin
CHELSEA THERAPEUTICS INTERNATIONAL LTD.	Directeur/Membre du Conseil	10/07/2012
AMICUS THERAPEUTICS, INC.	President	01/05/2004
Enzon Pharmaceuticals, Inc.	Directeur Technique/Scientifique/R&D	02/09/2003
Lifearc	President	01/09/2003
AERES Biomedical Ltd.	Directeur/Membre du Conseil	-